<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">44306</article-id><article-id pub-id-type="doi">10.7554/eLife.44306</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-127756"><name><surname>Shi</surname><given-names>Kaixuan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-127757"><name><surname>Yin</surname><given-names>Xia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-127758"><name><surname>Cai</surname><given-names>Mei-Chun</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-127759"><name><surname>Yan</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-127760"><name><surname>Jia</surname><given-names>Chenqiang</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-127762"><name><surname>Ma</surname><given-names>Pengfei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-127763"><name><surname>Zhang</surname><given-names>Shengzhe</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-127764"><name><surname>Zhang</surname><given-names>Zhenfeng</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-127766"><name><surname>Gu</surname><given-names>Zhenyu</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-127765"><name><surname>Zhang</surname><given-names>Meiying</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-127767"><name><surname>Di</surname><given-names>Wen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-11"/><xref ref-type="other" rid="par-17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-127237"><name><surname>Zhuang</surname><given-names>Guanglei</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8141-5096</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-10"/><xref ref-type="other" rid="par-15"/><xref ref-type="other" rid="par-16"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">School of Medicine</institution>, <institution>Shanghai Jiao Tong University</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><aff id="aff2"><institution content-type="dept">State Key Laboratory of Oncogenes and Related Genes</institution>, <institution>Shanghai Cancer Institute</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><aff id="aff3"><institution content-type="dept">Precision Oncology Lab</institution>, <institution>GenenDesign Co Ltd</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><aff id="aff4"><institution content-type="dept">School of Biomedical Engineering</institution>, <institution>Shanghai Jiao Tong University</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-31092"><name><surname>Zwart</surname><given-names>Wilbert</given-names></name><role>Reviewing editor</role><aff><institution>Netherlands Cancer Institute</institution>, <country>Netherlands</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>fudoczhang82@126.com</email> (MZ);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>diwen163@163.com</email> (WD);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>zhuanglab@163.com</email> (GZ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>05</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e44306</elocation-id><history><date date-type="received"><day>11</day><month>12</month><year>2018</year></date><date date-type="accepted"><day>02</day><month>05</month><year>2019</year></date></history><permissions><copyright-statement>Â© 2019, Shi et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Shi et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-44306-v1.pdf"/><abstract><p>PAX8 is a prototype lineage-survival oncogene in epithelial ovarian cancer. However, neither its underlying pro-tumorigenic mechanisms nor potential therapeutic implications have been adequately elucidated. Here, we identified an ovarian lineage-specific PAX8 regulon using modified cancer outlier profile analysis, in which PAX8-FGF18 axis was responsible for promoting cell migration in an autocrine fashion. An image-based drug screen pinpointed that PAX8 expression was potently inhibited by small-molecules against histone deacetylases (HDACs). Mechanistically, HDAC blockade altered histone H3K27 acetylation occupancies and perturbed the super-enhancer topology associated with PAX8 gene locus, resulting in epigenetic downregulation of PAX8 transcripts and related targets. HDAC antagonists efficaciously suppressed ovarian tumor growth and spreading as single agents, and exerted synergistic effects in combination with standard chemotherapy. These findings provide mechanistic and therapeutic insights for PAX8-addicted ovarian cancer. More generally, our analytic and experimental approach represents an expandible paradigm for identifying and targeting lineage-survival oncogenes in diverse human malignancies.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81472537</award-id><principal-award-recipient><name><surname>Zhuang</surname><given-names>Guanglei</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Shanghai Municipal Commission of Health and Family Planning</institution></institution-wrap></funding-source><award-id>20174Y0043</award-id><principal-award-recipient><name><surname>Cai</surname><given-names>Mei-Chun</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Program of Shanghai Hospital Development Center</institution></institution-wrap></funding-source><award-id>16CR2001A</award-id><principal-award-recipient><name><surname>Di</surname><given-names>Wen</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100008233</institution-id><institution>Shanghai Jiao Tong University School of Medicine</institution></institution-wrap></funding-source><award-id>YG2016MS51</award-id><principal-award-recipient><name><surname>Yin</surname><given-names>Xia</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>The State Key Laboratory of Oncogenes and Related Genes</institution></institution-wrap></funding-source><award-id>SB17-06</award-id><principal-award-recipient><name><surname>Cai</surname><given-names>Mei-Chun</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Shanghai Sailing Program</institution></institution-wrap></funding-source><award-id>18YF1413200</award-id><principal-award-recipient><name><surname>Ma</surname><given-names>Pengfei</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>National Key R&amp;D Program of China</institution></institution-wrap></funding-source><award-id>2016YFC1302900</award-id><principal-award-recipient><name><surname>Di</surname><given-names>Wen</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003399</institution-id><institution>Science and Technology Commission of Shanghai Municipality</institution></institution-wrap></funding-source><award-id>18441904800</award-id><principal-award-recipient><name><surname>Di</surname><given-names>Wen</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution>The Shanghai Institutions of Higher Learning</institution></institution-wrap></funding-source><award-id>Eastern Scholar</award-id><principal-award-recipient><name><surname>Zhuang</surname><given-names>Guanglei</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81672714</award-id><principal-award-recipient><name><surname>Zhuang</surname><given-names>Guanglei</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81772770</award-id><principal-award-recipient><name><surname>Di</surname><given-names>Wen</given-names></name></principal-award-recipient></award-group><award-group id="par-12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81802584</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Meiying</given-names></name></principal-award-recipient></award-group><award-group id="par-13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81802734</award-id><principal-award-recipient><name><surname>Ma</surname><given-names>Pengfei</given-names></name></principal-award-recipient></award-group><award-group id="par-14"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81802809</award-id><principal-award-recipient><name><surname>Cai</surname><given-names>Mei-Chun</given-names></name></principal-award-recipient></award-group><award-group id="par-15"><funding-source><institution-wrap><institution>Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support</institution></institution-wrap></funding-source><award-id>20161313</award-id><principal-award-recipient><name><surname>Zhuang</surname><given-names>Guanglei</given-names></name></principal-award-recipient></award-group><award-group id="par-16"><funding-source><institution-wrap><institution>Shanghai Rising-Star Program</institution></institution-wrap></funding-source><award-id>16QA1403600</award-id><principal-award-recipient><name><surname>Zhuang</surname><given-names>Guanglei</given-names></name></principal-award-recipient></award-group><award-group id="par-17"><funding-source><institution-wrap><institution>Shanghai Municipal Commission of Health and Family Planning</institution></institution-wrap></funding-source><award-id>2017ZZ02016,ZY(2018-2020)-FWTX-3006</award-id><principal-award-recipient><name><surname>Di</surname><given-names>Wen</given-names></name></principal-award-recipient></award-group><award-group id="par-18"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003399</institution-id><institution>Science and Technology Commission of Shanghai Municipality</institution></institution-wrap></funding-source><award-id>16140904401</award-id><principal-award-recipient><name><surname>Yin</surname><given-names>Xia</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The institutional animal care and use committee of Ren Ji Hospital approved all animal protocols (permit-number: m20170205) and all animal experiments were in accordance with Ren Ji Hospital policies on the care, welfare, and treatment of laboratory animals.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The sequencing data have been deposited in NCBI SRA database(http://www.ncbi.nlm.nih.gov/sra/) under the accession number SRP153266.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Shi K</collab><collab>Yin X</collab><collab>Cai MC</collab><collab>Yan Y</collab><collab>Jia C</collab><collab>Ma P</collab><collab>Zhang S</collab><collab>Zhang Z</collab><collab>Gu Z</collab><collab>Zhang M</collab><collab>Di W</collab><collab>Zhuang G</collab></person-group><year iso-8601-date="2018">2018</year><source>RNAseq of ovarian cancer cell lines: HDAC inhibitors,sgPAX8 treatment</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRP153266">https://www.ncbi.nlm.nih.gov/sra/?term=SRP153266</ext-link><comment>NCBI Sequence Read Archive, SRP153266</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-44306-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>